George Ioannidis | Health Professions | Best Researcher Award

Posted on by Academic achievements

Dr. George Ioannidis | Health Professions | Best Researcher Award

Associate Professor at McMaster University, Canada

Dr. George Ioannidis is a distinguished academic and researcher specializing in health research methodology and aging sciences. Currently, he holds the position of Associate Professor in the Faculty of Medicine, Health Sciences, at McMaster University, and serves as the Eli Lilly Canada Endowed Chair in Osteoporosis. He is also the Deputy Director at the GERAS Centre for Aging Research, where he contributes extensively to advancing knowledge in aging, osteoporosis, and musculoskeletal health. With over two decades of experience, Dr. Ioannidis is a leading voice in evidence-based healthcare research and education.

Profile

Scopus

Education 🎓

  • PhD in Health Research Methodology (2009)
    McMaster University, Ontario
    Focused on statistical modeling and clinical trial analysis.
  • MSc in Human Biodynamics (1996)
    McMaster University, Ontario
    Specialized in biomechanics and physical performance.
  • BA in Physical Education (1992)
    McMaster University, Ontario

He has also pursued specialized training in statistical analysis, economic evaluations, and design thinking from institutions such as SAS, Cochrane Collaboration, and McMaster University Institute for Research on Aging.

Professional Experience 💼

Dr. Ioannidis has held key roles in academia and research:

  • Associate Professor (2024–Present) at McMaster University.
  • Deputy Director (2013–Present) at GERAS Centre for Aging Research, Hamilton Health Sciences.
  • Research Consultant (2014–Present) for Medical Pharmacies Group Limited.

Earlier in his career, he served as Assistant Professor (2010–2016) and Research Associate at McMaster University, contributing to transformative health research initiatives.

Research Interests 🔬

Dr. Ioannidis’s research focuses on:

  • Aging and osteoporosis.
  • Musculoskeletal health.
  • Methodological advancements in clinical trials and systematic reviews.
  • The impact of frailty and social isolation on older adults.

Through innovative approaches, he bridges statistical methodologies with clinical applications, aiming to improve outcomes for aging populations.

Awards and Honors 🏆

Dr. Ioannidis has been recognized nationally and internationally, including:

  • Eli Lilly Canada Chair in Osteoporosis (2024–Present).
  • Presidential Lightning Science Oral Award (2024), American Geriatrics Society.
  • Editors’ Choice Publication Award (2021), Age and Ageing.
  • Numerous travel and research fellowships from Osteoporosis Canada, CIHR, and Procter & Gamble Pharmaceuticals.

Publications 📚

Dr. Ioannidis has authored numerous influential papers across prominent journals, including:

Hip fracture rate and osteoporosis treatment in Ontario: A population-based retrospective cohort study

  • Year: 2024
  • Citations: 0

Canadian Inpatient Orthogeriatric Models of Care: A Mixed Methods Survey of Facilitators and Barriers

  • Year: 2024
  • Citations: 0

Axial Spondyloarthritis: Does Magnetic Resonance Imaging Classification Improve Report Interpretation

  • Year: 2024
  • Citations: 0

Mapping sedentary behaviour (MAPS-B) in winter and spring using wearable sensors, indoor positioning systems, and diaries in older adults who are pre-frail and frail: A feasibility longitudinal study

  • Year: 2024
  • Citations: 1

Automatic Radar-Based Step Length Measurement in the Home for Older Adults Living with Frailty

  • Year: 2024
  • Citations: 0

Creating dementia-friendly communities: Challenging stigma and building understanding through public education

  • Year: 2024 (In press)
  • Citations: 0

Associations between Osteosarcopenia and Falls, Fractures, and Frailty in Older Adults: Results From the Canadian Longitudinal Study on Aging (CLSA)

  • Year: 2024
  • Citations: 7

Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 Update

  • Year: 2023
  • Citations: 2

The Geras virtual frailty rehabilitation program to build resilience in older adults with frailty during COVID-19: a randomized feasibility trial

  • Year: 2023
  • Citations: 2

Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 Update

  • Year: 2023
  • Citations: 33

Conclusion ✨

Dr. George Ioannidis exemplifies the qualities of an outstanding researcher through his innovative contributions to aging and osteoporosis research, impactful mentorship, and commitment to evidence-based practices. His leadership roles and academic accolades position him as a leader in his field, and with minor enhancements in interdisciplinary collaboration and global outreach, he could further solidify his legacy as a pioneer in health research. He is a highly deserving candidate for the Best Researcher Award.

Dr. Charles Gaillard | Health Professions | Best Researcher Award

Posted on by Academic achievements

Dr. Charles Gaillard | Health Professions | Best Researcher Award

Dr. Charles Gaillard, Centre Hospitalier Regional et Universitaire de Tours, France

Dr. Charles Gaillard is a dedicated urologist currently completing his medical training with a focus on transplantation and genitourinary oncology. He holds a series of advanced diplomas, including a Diplôme Inter-Universitaire in Oncologie Génito-Urinaire and a Thèse d’Exercice in Medicine, which he defended in 2022 on the topic of renal transplantation and drainage. Dr. Gaillard’s research, particularly his study on the necessity of drainage in renal transplantation, was published in FJUROL in August 2024 and awarded the Silver Medal with Honors from the jury. He has gained extensive clinical experience through internships at leading hospitals in Lyon and Tours, working under prominent professors in urology and vascular surgery.

Professional Profile:

Scopus

Suitability for the Award:

Dr. Gaillard’s research aligns well with the Best Researcher Award, especially given his focus on transplantation, surgical innovation, and urological treatment methodologies. His work contributes both to scientific understanding and practical advances in post-operative patient care, making a meaningful impact in his field.

Academic Background:

Dr. Charles Gaillard earned several prestigious diplomas in his field, including a Diplôme Inter-Universitaire in Genito-Urinary Oncology (2023), Thesis in Medicine on Renal Transplantation (2022), and Diplôme Universitaire in Urinary Lithiasis (2020). He has undergone specialized training in organ transplantation and urology across top institutions such as Sorbonne University and Paris-Lyon-Tours.

Clinical Experience:

Dr. Gaillard’s internship includes comprehensive work at Hôpital Edouard Herriot, Hôpital Bretonneau, and Clinique du Pôle Léonard de Vinci, where he honed his skills in urology, vascular surgery, and renal transplantation under expert supervision.

Research Focus & Achievements:

His doctoral thesis on renal transplantation—titled “Is Redon Drainage Essential in Renal Transplantation?”—was published in FJUROL (2024) and won the Silver Medal with Jury Honors. The study explored risk factors associated with the necessity of drainage in renal transplant surgeries.

Honors & Recognition:

Dr. Gaillard’s dedication to research and clinical excellence has earned him recognition in his field, including Medal of Silver with Jury Congratulations for his groundbreaking research on transplantation.

Publication Top Notes:

  • Cut-off time for surgery and prediction of orchiectomy in spermatic cord torsion: a retrospective multicentric study over 15 years
    • Journal: World Journal of Urology, 2023,
    • Citations: 2
  • Torsion of the spermatic cord in adults: a multicenter experience in adults with surgical exploration for acute scrotal pain with suspected testicular torsion
    • Journal: Asian Journal of Andrology, 2022,
    • Citations: 7
  • TORSAFUF – Surgical exploration for torsion of spermatic cord suspicion and risk factors for unnecessary surgery: Results of a French nationwide retrospective study on 2940 patients
    • Journal: Progres en Urologie, 2022
    • Citations: 2
  • Contralateral Orchiopexy at the Time of Urgent Scrotal Exploration-Is It Safe? A Propensity Score Matched Analysis from the TORSAFUF Cohort
    • Journal: Journal of Urology, 2021
    • Citations: 5

 

 

Dr. Mohammad Mehdi Mousavian – Health Professions – Best Researcher Award

Posted on by Academic achievements

Dr. Mohammad Mehdi Mousavian - Health Professions - Best Researcher Award

Massachusetts General Hospital - United States

Professional Profiles

ORCID

Early Academic Pursuits

Mohammad Mehdi Mousavian's academic journey is marked by an impressive array of degrees and accolades, demonstrating his dedication to both the medical and dental fields. His academic career began at Princeton University, where he earned a Bachelor of Arts from the Near Eastern Studies Department, with a minor in Persian literature. This early education provided him with a broad cultural and linguistic foundation, which he has built upon throughout his extensive career.

In 2015, Mousavian expanded his expertise by earning a Master in Law (ML) from the University of Pennsylvania Law School. This legal education complemented his scientific and medical pursuits, providing a unique perspective on healthcare-related legal issues.

Professional Endeavors

Dr. Mousavian has pursued a comprehensive and multidisciplinary training in both medicine and dentistry. His professional training began at the University of Pennsylvania School of Dental Medicine, where he graduated summa cum laude with a Doctor of Dental Medicine (DMD) degree in May 2019. His exemplary performance earned him Research Honors, Community Service Honors, and Oral Surgery Honors.

Following his dental education, he completed a General Practice Residency in Dentistry at Harvard School of Dental Medicine and Massachusetts General Hospital (MGH) in June 2020. He further enhanced his educational qualifications by earning a Master of Science in Education (MSEd) from the MGH Institute of Health Professions in June 2022, focusing on healthcare education.

Continuing his journey in medicine, Mousavian graduated from Harvard Medical School with a Doctor of Medicine (MD) degree in May 2023. He achieved high scores on his Step 2 CK exam (253) and received Honors with Distinction in his Medicine Sub-Internship and all clinical electives. His medical training included a 2-year general surgery credit and a 5-month anesthesia credit during his Oral and Maxillofacial Surgery Residency at MGH, which he will complete in June 2026.

Additionally, Mousavian is set to receive his PhD in Healthcare Education from the MGH Institute of Health Professions in January 2024. His dissertation focuses on gender-affirming care education, highlighting his commitment to inclusive and equitable healthcare education.

Contributions and Research Focus On Health Professions

Dr. Mousavian’s contributions to the medical and dental fields are extensive and multifaceted. His research has focused on various critical areas, including oral and maxillofacial surgery, dental education, and gender-affirming care. His dissertation on gender-affirming care education underscores his commitment to addressing disparities and improving healthcare outcomes for marginalized communities.

His clinical expertise is complemented by his robust research background, particularly in oral surgery. His research honors from his time at the University of Pennsylvania and his ongoing contributions to healthcare education at MGH reflect his dedication to advancing the field through both practical and theoretical approaches.

Accolades and Recognition In Health Professions

Throughout his career, Dr. Mousavian has received numerous accolades that highlight his academic and professional excellence. His summa cum laude graduation from the University of Pennsylvania School of Dental Medicine, coupled with multiple honors in research, community service, and oral surgery, showcase his commitment to excellence in dentistry. His performance in medical school, including high Step 2 CK scores and numerous clinical honors, further attests to his dedication and skill in the medical field.

Impact and Influence

Dr. Mousavian’s impact extends beyond his clinical and research contributions. His focus on healthcare education, particularly in gender-affirming care, positions him as a leader in promoting inclusive and equitable healthcare practices. His multidisciplinary approach, encompassing dentistry, medicine, and law, allows him to address complex healthcare challenges from multiple perspectives.

His involvement in both medical and dental education ensures that he influences the next generation of healthcare professionals, instilling in them the values of comprehensive care and lifelong learning.

Legacy and Future Contributions For Health Professions

As Dr. Mousavian continues his residency in Oral and Maxillofacial Surgery and completes his PhD, his future contributions are poised to be significant. His work in healthcare education, particularly his emphasis on gender-affirming care, is expected to have a lasting impact on the field, promoting more inclusive and compassionate healthcare practices.

His extensive training and diverse academic background uniquely position him to address the evolving challenges in healthcare. Dr. Mousavian’s ongoing commitment to research, education, and clinical excellence will undoubtedly leave a lasting legacy, influencing both current practices and future advancements in medicine and dentistry.

In summary, Dr. Mohammad Mehdi Mousavian’s journey through diverse and rigorous academic and professional pathways highlights his commitment to excellence in healthcare. His contributions to medical and dental education, combined with his focus on inclusive care, ensure his enduring impact on the field and his role as a leader in promoting comprehensive, patient-centered healthcare.

Notable Publications

What are the barriers to health professionals' training on gender-affirming care from patients' and clinicians’ perspectives? 2024